Craneware (CRW) Competitors GBX 1,456 +8.00 (+0.55%) As of 05/22/2026 12:07 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsInsider TradesBuy This Stock CRW vs. EMIS, INS, KOO, COG, and INHCShould you buy Craneware stock or one of its competitors? MarketBeat compares Craneware with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry. CRW vs. EMISCRW vs. INSCRW vs. KOOCRW vs. COGCRW vs. INHCHow does Craneware compare to EMIS Group?EMIS Group (LON:EMIS) and Craneware (LON:CRW) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability. Does the media favor EMIS or CRW? In the previous week, Craneware had 1 more articles in the media than EMIS Group. MarketBeat recorded 1 mentions for Craneware and 0 mentions for EMIS Group. Craneware's average media sentiment score of 0.67 beat EMIS Group's score of 0.00 indicating that Craneware is being referred to more favorably in the news media. Company Overall Sentiment EMIS Group Neutral Craneware Positive Is EMIS or CRW a better dividend stock? EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays an annual dividend of GBX 41.96 per share and has a dividend yield of 2.9%. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware pays out 66.7% of its earnings in the form of a dividend. Craneware is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has more volatility and risk, EMIS or CRW? EMIS Group has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market. Comparatively, Craneware has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market. Do analysts recommend EMIS or CRW? Craneware has a consensus price target of GBX 2,297.75, indicating a potential upside of 57.81%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than EMIS Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EMIS Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, EMIS or CRW? EMIS Group has higher earnings, but lower revenue than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEMIS Group£176.86M0.00£30.48M£0.47N/ACraneware£211.33M2.38£14.27M£62.9023.15 Is EMIS or CRW more profitable? EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 10.63%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.Company Net Margins Return on Equity Return on Assets EMIS Group17.23% 23.17% 7.99% Craneware 10.63%6.65%2.28% Do institutionals and insiders hold more shares of EMIS or CRW? 105.6% of EMIS Group shares are owned by institutional investors. Comparatively, 36.8% of Craneware shares are owned by institutional investors. 3.6% of EMIS Group shares are owned by company insiders. Comparatively, 10.2% of Craneware shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryCraneware beats EMIS Group on 11 of the 17 factors compared between the two stocks.How does Craneware compare to Instem?Craneware (LON:CRW) and Instem (LON:INS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Does the media prefer CRW or INS? In the previous week, Craneware had 1 more articles in the media than Instem. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Instem. Craneware's average media sentiment score of 0.67 beat Instem's score of 0.00 indicating that Craneware is being referred to more favorably in the media. Company Overall Sentiment Craneware Positive Instem Neutral Which has preferable valuation and earnings, CRW or INS? Craneware has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCraneware£211.33M2.38£14.27M£62.9023.15Instem£61.63M0.00£3.34M£0.14N/A Is CRW or INS more profitable? Craneware has a net margin of 10.63% compared to Instem's net margin of 5.50%. Craneware's return on equity of 6.65% beat Instem's return on equity.Company Net Margins Return on Equity Return on Assets Craneware10.63% 6.65% 2.28% Instem 5.50%6.35%4.62% Do analysts recommend CRW or INS? Craneware currently has a consensus price target of GBX 2,297.75, suggesting a potential upside of 57.81%. Given Craneware's stronger consensus rating and higher possible upside, equities research analysts plainly believe Craneware is more favorable than Instem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Instem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, CRW or INS? Craneware has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market. Comparatively, Instem has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market. Do institutionals and insiders have more ownership in CRW or INS? 36.8% of Craneware shares are held by institutional investors. Comparatively, 65.9% of Instem shares are held by institutional investors. 10.2% of Craneware shares are held by company insiders. Comparatively, 30.0% of Instem shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryCraneware beats Instem on 10 of the 15 factors compared between the two stocks.How does Craneware compare to Kooth?Craneware (LON:CRW) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends. Which has more risk and volatility, CRW or KOO? Craneware has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market. Comparatively, Kooth has a beta of 1.238, suggesting that its share price is 24% more volatile than the broader market. Do analysts prefer CRW or KOO? Craneware presently has a consensus target price of GBX 2,297.75, indicating a potential upside of 57.81%. Kooth has a consensus target price of GBX 330, indicating a potential upside of 94.12%. Given Kooth's higher possible upside, analysts clearly believe Kooth is more favorable than Craneware.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Kooth 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer CRW or KOO? In the previous week, Kooth had 1 more articles in the media than Craneware. MarketBeat recorded 2 mentions for Kooth and 1 mentions for Craneware. Craneware's average media sentiment score of 0.67 beat Kooth's score of 0.00 indicating that Craneware is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Craneware 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kooth 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, CRW or KOO? Craneware has higher revenue and earnings than Kooth. Craneware is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCraneware£211.33M2.38£14.27M£62.9023.15Kooth£63.29M0.97£4.00M£7.0024.29 Is CRW or KOO more profitable? Craneware has a net margin of 10.63% compared to Kooth's net margin of 4.12%. Kooth's return on equity of 8.84% beat Craneware's return on equity.Company Net Margins Return on Equity Return on Assets Craneware10.63% 6.65% 2.28% Kooth 4.12%8.84%10.12% Do institutionals & insiders believe in CRW or KOO? 36.8% of Craneware shares are owned by institutional investors. Comparatively, 21.7% of Kooth shares are owned by institutional investors. 10.2% of Craneware shares are owned by company insiders. Comparatively, 30.6% of Kooth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryCraneware beats Kooth on 8 of the 15 factors compared between the two stocks.How does Craneware compare to Cambridge Cognition?Craneware (LON:CRW) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership. Which has more volatility and risk, CRW or COG? Craneware has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.832, indicating that its share price is 17% less volatile than the broader market. Do analysts prefer CRW or COG? Craneware currently has a consensus price target of GBX 2,297.75, suggesting a potential upside of 57.81%. Cambridge Cognition has a consensus price target of GBX 56, suggesting a potential upside of 64.71%. Given Cambridge Cognition's higher probable upside, analysts plainly believe Cambridge Cognition is more favorable than Craneware.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Cambridge Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to CRW or COG? In the previous week, Craneware and Craneware both had 1 articles in the media. Craneware's average media sentiment score of 0.67 beat Cambridge Cognition's score of 0.00 indicating that Craneware is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Craneware 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cambridge Cognition 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, CRW or COG? Craneware has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCraneware£211.33M2.38£14.27M£62.9023.15Cambridge Cognition£9.40M1.68-£1.58M-£3.90N/A Is CRW or COG more profitable? Craneware has a net margin of 10.63% compared to Cambridge Cognition's net margin of -17.82%. Craneware's return on equity of 6.65% beat Cambridge Cognition's return on equity.Company Net Margins Return on Equity Return on Assets Craneware10.63% 6.65% 2.28% Cambridge Cognition -17.82%-62.89%-0.30% Do institutionals and insiders hold more shares of CRW or COG? 36.8% of Craneware shares are held by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are held by institutional investors. 10.2% of Craneware shares are held by company insiders. Comparatively, 3.4% of Cambridge Cognition shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryCraneware beats Cambridge Cognition on 12 of the 14 factors compared between the two stocks.How does Craneware compare to Induction Healthcare Group?Craneware (LON:CRW) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends. Does the media refer more to CRW or INHC? In the previous week, Craneware had 1 more articles in the media than Induction Healthcare Group. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Induction Healthcare Group. Craneware's average media sentiment score of 0.67 beat Induction Healthcare Group's score of 0.00 indicating that Craneware is being referred to more favorably in the media. Company Overall Sentiment Craneware Positive Induction Healthcare Group Neutral Which has better earnings & valuation, CRW or INHC? Craneware has higher revenue and earnings than Induction Healthcare Group. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCraneware£211.33M2.38£14.27M£62.9023.15Induction Healthcare Group£12.57M0.72-£5.12M-£5.54N/A Which has more volatility & risk, CRW or INHC? Craneware has a beta of 0.28, indicating that its stock price is 72% less volatile than the broader market. Comparatively, Induction Healthcare Group has a beta of -0.41, indicating that its stock price is 141% less volatile than the broader market. Do insiders and institutionals hold more shares of CRW or INHC? 36.8% of Craneware shares are held by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are held by institutional investors. 10.2% of Craneware shares are held by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is CRW or INHC more profitable? Craneware has a net margin of 10.63% compared to Induction Healthcare Group's net margin of -23.86%. Craneware's return on equity of 6.65% beat Induction Healthcare Group's return on equity.Company Net Margins Return on Equity Return on Assets Craneware10.63% 6.65% 2.28% Induction Healthcare Group -23.86%-14.58%-7.32% Do analysts prefer CRW or INHC? Craneware currently has a consensus price target of GBX 2,297.75, suggesting a potential upside of 57.81%. Given Craneware's stronger consensus rating and higher probable upside, research analysts clearly believe Craneware is more favorable than Induction Healthcare Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Induction Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryCraneware beats Induction Healthcare Group on 14 of the 16 factors compared between the two stocks. Get Craneware News Delivered to You Automatically Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRW vs. The Competition ExportMetricCranewareHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£495.75M£304.98M£6.41B£3.04BDividend Yield2.31%5.60%2.76%6.10%P/E Ratio23.15188.7621.01365.89Price / Sales2.38120.03555.7187,843.39Price / Cash14.7247.1444.5727.89Price / Book1.565.3010.377.69Net Income£14.27M-£22.78M£3.56B£5.89B7 Day Performance3.26%1.61%5.10%8.05%1 Month Performance-6.91%-0.93%3.58%2.82%1 Year Performance-29.66%-11.41%34.18%77.61% Craneware Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRWCraneware3.1751 of 5 starsGBX 1,456+0.6%GBX 2,297.75+57.8%-31.0%£495.75M£211.33M23.15734EMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560INSInstemN/AN/AN/AN/A£199.62M£61.63M5,928.57500KOOKooth2.1451 of 5 starsGBX 136.71-0.9%GBX 330+141.4%+6.3%£49.59M£63.29M19.53478News CoverageCOGCambridge Cognition1.2565 of 5 starsGBX 35-2.8%GBX 56+60.0%-10.3%£16.29M£9.40MN/A80News CoverageGap Down Related Companies and Tools Related Companies EMIS Group Competitors Instem Competitors Kooth Competitors Cambridge Cognition Competitors Induction Healthcare Group Competitors Renalytix Competitors Feedback Competitors IQ-AI Competitors DeepVerge Competitors Sensyne Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRW) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Craneware plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Craneware With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
